- Home
- RELL vs CRVS Comparison
RELL vs CRVS Comparison
Compare RELL & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RELL
- CRVS
- Stock Information
- Founded
- RELL 1947
- CRVS 2014
- Country
- RELL United States
- CRVS United States
- Employees
- RELL N/A
- CRVS N/A
- Industry
- RELL Electronic Components
- CRVS Biotechnology: Pharmaceutical Preparations
- Sector
- RELL Technology
- CRVS Health Care
- Exchange
- RELL Nasdaq
- CRVS Nasdaq
- Market Cap
- RELL 166.3M
- CRVS 161.4M
- IPO Year
- RELL N/A
- CRVS 2016
- Fundamental
- Price
- RELL $11.40
- CRVS $4.03
- Analyst Decision
- RELL
- CRVS Buy
- Analyst Count
- RELL 0
- CRVS 3
- Target Price
- RELL N/A
- CRVS $5.75
- AVG Volume (30 Days)
- RELL 52.1K
- CRVS 405.1K
- Earning Date
- RELL 10-09-2024
- CRVS 08-06-2024
- Dividend Yield
- RELL 2.10%
- CRVS N/A
- EPS Growth
- RELL N/A
- CRVS N/A
- EPS
- RELL 0.00
- CRVS N/A
- Revenue
- RELL $196,460,000.00
- CRVS N/A
- Revenue This Year
- RELL $14.22
- CRVS N/A
- Revenue Next Year
- RELL $13.00
- CRVS N/A
- P/E Ratio
- RELL $2,686.19
- CRVS N/A
- Revenue Growth
- RELL N/A
- CRVS N/A
- 52 Week Low
- RELL $8.08
- CRVS $1.05
- 52 Week High
- RELL $14.30
- CRVS $4.75
- Technical
- Relative Strength Index (RSI)
- RELL 43.74
- CRVS 58.05
- Support Level
- RELL $11.75
- CRVS $3.90
- Resistance Level
- RELL $12.23
- CRVS $4.75
- Average True Range (ATR)
- RELL 0.27
- CRVS 0.30
- MACD
- RELL -0.03
- CRVS -0.08
- Stochastic Oscillator
- RELL 3.37
- CRVS 18.18
About RELL Richardson Electronics Ltd.
Richardson Electronics Ltd provides engineered solutions, power grid, and microwave tubes and related consumables, power conversion, RF and microwave components, high-value flat panel detector solutions, replacement parts, tubes, and service training for diagnostic imaging equipment and customized display solutions. Its products have applications in alternative energy, healthcare, aviation, broadcast, communications, industrial, marine, medical, military, scientific, and semiconductor markets. The company segments include PMT (Power and Microwave Technologies Group), Canvys, (Green Energy Solutions) GES, and Healthcare reportable segments. The company derives the majority of its revenues from the PMT segment.
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical engaged in developing drugs and antibodies that target the critical cellular elements of the immune system. It focuses on the development of immune modulator product candidates to treat COVID-19, T-cell lymphomas, other cancers, and autoimmune diseases. The company's primary product candidate is Soquelitinib (CPI-818), an oral, small-molecule drug that selectively inhibits ITK (interleukin-2-inducible T cell kinase). The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).